back to top
HomeTagsMerck

Merck

Merck (MRK) swings to revenue in Q2 on larger revenues; earnings beat | AlphaStreet

Pharmaceutical firm Merck & Co. Inc. (NYSE: MRK) reported web revenue for the second quarter of 2024, on an adjusted foundation, in comparison with...

Merck acquires EyeBio to spice up retinal illness remedy By Investing.com

RAHWAY, N.J. - Merck & Co., Inc. (NYSE: MRK) has accomplished the acquisition of Eyebiotech Restricted (EyeBio), now a completely built-in subsidiary, enhancing its...

Most Popular

spot_img